tunicamycin   Click here for help

GtoPdb Ligand ID: 13510

Synonyms: tunicamycin A | tunicamycin B2 | tunicamycin V
PDB Ligand
Compound class: Natural product
Comment: Tunicamycin is a nucleoside antibacterial compound, originally isolated from culture broth of Streptomyces lysosuperificus [1]. It inhibits phospho-N-acetylmuramoyl-pentapeptide-transferase (MraY, translocase I), an essential enzyme in bacterial peptidoglycan biosynthesis.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 20
Hydrogen bond donors 11
Rotatable bonds 22
Topological polar surface area 306.37
Molecular weight 830.92
XLogP 2.44
No. Lipinski's rules broken 4

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)CCCCCCCCC/C=C/C(=O)N[C@@H]1[C@H]([C@H]([C@@H](C[C@H]([C@@H]2[C@H]([C@H]([C@H](N3C=CC(=O)NC3=O)O2)O)O)O)O[C@H]1O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)NC(=O)C)O)O
Isomeric SMILES CC(C)CCCCCCCCC/C=C/C(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)NC(=O)C)C[C@H]([C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)O)O)O
InChI InChI=1S/C38H62N4O16/c1-19(2)13-11-9-7-5-4-6-8-10-12-14-24(46)40-27-31(51)28(48)22(55-37(27)58-36-26(39-20(3)44)30(50)29(49)23(18-43)56-36)17-21(45)34-32(52)33(53)35(57-34)42-16-15-25(47)41-38(42)54/h12,14-16,19,21-23,26-37,43,45,48-53H,4-11,13,17-18H2,1-3H3,(H,39,44)(H,40,46)(H,41,47,54)/b14-12+/t21-,22-,23-,26-,27-,28+,29-,30-,31-,32+,33-,34-,35-,36-,37+/m1/s1
InChI Key MEYZYGMYMLNUHJ-DIRMKAHISA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Takatsuki A, Arima K, Tamura G. (1971)
Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin.
J Antibiot (Tokyo), 24 (4): 215-23. [PMID:5572750]